Helicobacter Pylori Diagnostics Market to Grow with a CAGR of 4.25% through 2028
Rising prevalence of helicobacter pylori infections and
increased awareness and screening programs are factors driving the Global
Helicobacter Pylori Diagnostics Market in the forecast period 2024-2028.
According to TechSci Research report, “Helicobacter
Pylori Diagnostics Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Helicobacter
Pylori Diagnostics Market stood at USD 531.52 Million in 2022 and is
anticipated to grow with a CAGR of 4.25% in the forecast period, 2024-2028. The global Helicobacter Pylori (H. pylori) diagnostics market has
witnessed remarkable growth in recent years. H. pylori is a bacterium that
infects the stomach lining and is a significant cause of various
gastrointestinal disorders, including gastritis, peptic ulcers, and even
stomach cancer. The diagnosis and management of H. pylori infections have
become increasingly vital in the field of healthcare. One of the
primary drivers of the H. pylori diagnostics market is the increasing
prevalence of H. pylori infections globally. According to the World
Gastroenterology Organization, around 50% of the world's population is
estimated to be infected with H. pylori. This high prevalence has led to an
upsurge in the demand for accurate diagnostic tests to identify and manage
these infections, driving market growth. Advancements in diagnostic technologies have played a
pivotal role in driving the H. pylori diagnostics market. Traditional methods
for diagnosing H. pylori, such as endoscopy and biopsy, are invasive and
costly. However, modern diagnostic tools, including serology tests, urea breath
tests, and molecular diagnostics, offer non-invasive and more cost-effective
alternatives. These technological advancements have made diagnosis more
accessible, leading to increased demand for testing, thereby boosting the
market.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Helicobacter Pylori Diagnostics Market.”
Growing awareness about the health risks
associated with H. pylori infections has led to an increase in screening and
diagnostic programs. Healthcare organizations and government bodies in many
countries are focusing on early detection and treatment of H. pylori infections
to reduce the incidence of associated diseases. As a result, there is a surge
in the number of diagnostic tests performed, contributing to market growth.
H. pylori infections are closely
associated with a range of gastrointestinal diseases, including gastritis,
peptic ulcers, and gastric cancer. The rising incidence of these diseases,
often attributed to H. pylori, is driving the demand for diagnostic tests.
Healthcare providers are increasingly emphasizing the need for accurate and
early diagnosis to better manage and treat these conditions, further propelling
market growth. Innovations in the field of H. pylori
diagnostics continue to drive market expansion. Research and development
efforts are leading to the introduction of more accurate and efficient
diagnostic methods. Manufacturers are investing in the development of new
diagnostic devices, tests, and software solutions, improving the overall
accuracy and convenience of H. pylori diagnostics.
The Global Helicobacter Pylori Diagnostics Market is
segmented into type, technology, end user and company.
Based on end user, the Hospitals & Clinics segment
has emerged as the predominant market leader. Hospitals and clinics are equipped
with state-of-the-art diagnostic tools, including endoscopy, serological tests,
and molecular diagnostics. These resources enable healthcare professionals to
accurately detect H. pylori infection and related conditions. Hospitals and
clinics often offer endoscopic examinations, which allow for direct
visualization of the stomach lining and biopsy sampling, resulting in precise
H. pylori detection. This method not only detects infection but also assesses
the extent of tissue damage, offering vital information for treatment planning.
Based on region, North America segment is expected to
grow during the forecast period. The United States and Canada have
been at the forefront of H. pylori research and development. Their commitment
to advancing medical knowledge and improving diagnostic methods has been
instrumental in driving the growth of the diagnostics market. Academic
institutions, research organizations, and biotechnology companies in North
America have been actively involved in developing new diagnostic technologies
and treatments for H. pylori infections. This culture of innovation has led to
a continuous stream of groundbreaking research, ensuring that the region
remains at the forefront of diagnostic advancements.
The Asia Pacific region is experiencing rapid market
growth. The lucrative nature of the H. pylori diagnostics market has attracted
substantial investments in Asia Pacific. Private companies and investors are
pouring resources into the development, marketing, and distribution of
diagnostic products. The fierce competition within the region has driven
innovation and lowered the cost of diagnostic tests, ultimately benefiting
patients.
Major companies operating in Global Helicobacter
Pylori Diagnostics Market are:
- Thermo Fisher Scientific inc.
- Biohit Oyj
- Quest Diagnostics Incorporated
- Meridian Bioscience
- Bio-Rad Laboratories
- Alpha Laboratories Ltd
- F. Hoffmann-La Roche Ltd
- Coris BioConcept
- Certest Biotec
- Epitope Diagnostics, Inc.
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“The global Helicobacter Pylori diagnostics market is
experiencing significant growth due to a combination of factors, including the
rising prevalence of H. pylori infections, technological advancements,
increased awareness, growing incidence of associated diseases, research and
development efforts, expanding healthcare infrastructure, and the demand for
point-of-care testing. As healthcare systems continue to evolve and emphasize
early diagnosis and effective management of helicobacter pylori infections, the
market is poised for further expansion in the years to come. This growth is not
only beneficial for diagnostic manufacturers but also for the overall health
and well-being of individuals at risk of helicobacter pylori-related diseases.,”
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Helicobacter Pylori Diagnostics Market By Type (Instruments,
Reagents, Services), By Technology (Immunoassays, POC, Molecular Diagnostics), By End user (Hospitals & Clinics, Ambulatory
Care Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Helicobacter Pylori Diagnostics Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Helicobacter Pylori Diagnostics Market.
Contact Us-
TechSci Research LLC
420 Lexington Avenue, Suite
300,
New York, United States-
10170
M: +13322586602
Email: [email protected]
Website: www.techsciresearch.com